Acadia Pharmaceuticals (Cencora / Lash Group)
Data Breach Class Action Lawsuit

May 22, 2024 -- Attention: victims of the Acadia Pharmaceuticals data breach.

Abington Cole + Ellery is investigating the data breach recently announced by Acadia Pharmaceuticals.

Acadia Pharmaceuticals data breach summary:

Unfortunately, at this time very little information is publicly available about the recently announced Acadia Pharmaceuticals data breach. A filing with the Attorney General of Texas on May 22, 2024, indicates that there was a data security breach affecting medical information of more than 3700 Texans. According to information filed with the Attorney General of Texas, notice of the data security breach is being sent to affected consumers in Texas.

This data breach appears to be part of the recently announced Cencora / Lash Group data breach. It is not clear if notices regarding this breach will come from Cencora / Lash Group, or from Acadia Pharmaceuticals, or from both.

It is unclear if Acadia Pharmaceuticals is offering credit monitoring and/or identity theft protection services to affected individuals at this time. Data Breach notices being sent to affected individuals by Cencora / Lash Group include an offer for 24 months of free credit monitoring and/or identity theft protection services.

Thousands of individuals were affected by the Acadia Pharmaceuticals data breach.

Breached data may include, but is not necessarily limited to: names, dates of birth, addresses, and medical data.

About Acadia Pharmaceuticals:

Acadia Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative medicines to address unmet medical needs in central nervous system disorders. The company was founded in 1993 and is headquartered in San Diego, California. Acadia Pharmaceuticals' primary area of research includes neurological and psychiatric conditions, with a focus on developing treatments that improve the lives of patients with these disorders.

Acadia Pharmaceuticals collaborates with academic institutions, research organizations, and other pharmaceutical companies to advance its research and development efforts. The company is committed to rigorous scientific research and innovation, aiming to bring effective treatments to patients with debilitating central nervous system disorders. Through these efforts, Acadia Pharmaceuticals strives to address significant medical needs and improve patient outcomes.

The Acadia Pharmaceuticals Website may have additional information about or provide periodic updates regarding the data breach.

For more information about steps you can take to possibly reduce the chances harm arising from a data breach, please review the following article: What are some steps you can take if you've been the victim of a data breach?

This website is not associated with nor authorized by Acadia Pharmaceuticals or any affiliated companies.